tradingkey.logo
tradingkey.logo

CAMP4 Therapeutics Corp

CAMP
4.000USD
-0.310-7.19%
Close 03/30, 16:00ETQuotes delayed by 15 min
78.02MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of CAMP4 Therapeutics Corp to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2023Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
155.75%6.29M
-15.72%-11.22M
---10.34M
---14.29M
---11.29M
-47.89%-9.69M
---6.55M
Net income from continuing operations
-203.37%-40.28M
-11.98%-15.10M
---12.59M
---12.43M
---13.28M
-15.30%-13.48M
---11.70M
Operating gains losses
-11.00%372.00K
117.70%910.00K
--430.00K
--421.00K
--418.00K
-2.79%418.00K
--430.00K
Other non-cash items
-65.97%163.00K
4.70%490.00K
--384.00K
--586.00K
--479.00K
16.13%468.00K
--403.00K
Change in working capital
5512.79%16.67M
-128.13%-369.00K
--428.00K
---3.72M
--297.00K
-63.41%1.31M
--3.59M
-Change in prepaid expenses
-111.68%-779.00K
-306.40%-419.00K
--317.00K
---7.00K
---368.00K
-76.83%203.00K
--876.00K
-Change in other current liabilities
4445.45%17.50M
--0.00
--0.00
---385.00K
--385.00K
----
----
Cash from non-recurring investing activities
Cash from operating activities
155.75%6.29M
-15.72%-11.22M
---10.34M
---14.29M
---11.29M
-47.89%-9.69M
---6.55M
Investing cash flow
Net cash from continuing investing activities
-100.00%0.00
---36.00K
--0.00
--279.00K
--263.00K
-100.00%0.00
--207.00K
Capital expenditures
-100.00%0.00
--0.00
--0.00
--279.00K
--263.00K
-100.00%0.00
--207.00K
Net cash flow from disposal of fixed assets
-100.00%0.00
---36.00K
--0.00
--279.00K
--263.00K
-100.00%0.00
--207.00K
Net cash flow from other investing activities
--0.00
--0.00
----
----
--0.00
----
----
Cash from non-current investing activities
Net cash flow from investing activities
100.00%0.00
--36.00K
--0.00
---279.00K
---263.00K
100.00%0.00
---207.00K
Financing cash flow
Cash flow from continuous financing activities
-60.88%28.59M
12375.65%47.38M
--72.00K
---151.00K
--73.06M
-90.15%-386.00K
---203.00K
Net cash flow from debt Issuance/repayment
81.25%-18.00K
84.44%-14.00K
---43.00K
---36.00K
---96.00K
-1.12%-90.00K
---89.00K
Net cash flow from common stock issuance/repurchase
-67.30%24.95M
104938.71%32.56M
--0.00
--0.00
--76.32M
3000.00%31.00K
--1.00K
Proceeds from stock option exercised by employees
-57.52%48.00K
--3.00K
----
----
--113.00K
----
----
Proceeds from issuance of warrants
--3.60M
----
----
----
----
----
----
Net cash flow from other financing activities
100.00%0.00
4636.09%14.83M
--115.00K
---115.00K
---3.27M
-184.35%-327.00K
---115.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
-60.88%28.59M
12375.65%47.38M
--72.00K
---151.00K
--73.06M
-90.15%-386.00K
---203.00K
Net cash flow
Beginning cash balance
1751.61%76.88M
185.83%40.68M
--50.95M
--65.66M
--4.15M
-75.90%14.23M
--59.06M
Current period cash flow changes
-43.30%34.88M
459.19%36.20M
---10.27M
---14.72M
--61.51M
-44.73%-10.08M
---6.96M
Ending cash balance
70.20%111.76M
1751.61%76.88M
--40.68M
--50.95M
--65.66M
-92.03%4.15M
--52.09M
Free cash flow
154.48%6.29M
-15.72%-11.22M
---10.34M
---14.56M
---11.55M
-43.37%-9.69M
---6.76M
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI